28888853Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono KMolecular genetics and metabolismAlkaline Phosphatase; Bone Diseases, Metabolic; Drug Monitoring; Hypophosphatasia; Immunoglobulin G; Recombinant Fusion ProteinsEnzyme Replacement Therapy; HumansKishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 09; 122(1-2):4-17.Mol Genet Metab2017-07-25T00:00:002017Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.cmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD011993Chemicals & Drugs6120.990711Recombinant Fusion ProteinsD016903Procedures10190.983245Drug Monitoring1ProfessorD056947Procedures340.996739Enzyme Replacement TherapyPediatricsClinicalChildren's Mercy Kansas CityD000469Chemicals & Drugs3180.976557Alkaline PhosphataseMD, FAAP, FACMG, CCDEricRushEric T. Rush0.000000000000000.00000000000000200Rush, Eric0000-0002-8147-7315Medical Director, Office of Faculty Affairs and DevelopmentAuthorship 881520.157490.157491authors10.258has subject areaD001851Disorders590.989875Bone Diseases, Metabolictrue1Medical Director, Office of Faculty Affairs and DevelopmentMedical Director, Office of Faculty Affairs and DevelopmentD006801Living Beings12067970.397999HumansD007014Disorders1100.978536HypophosphatasiaD007074Chemicals & Drugs16330.985157Immunoglobulin G